Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Interest & Investment Income (2016 - 2019)

Nu-Med Plus' Interest & Investment Income history spans 7 years, with the latest figure at $10.0 for Q1 2019.

  • Quarterly results put Interest & Investment Income at $10.0 for Q1 2019, down 71.43% from a year ago — trailing twelve months through Mar 2020 was $45.0 (changed 0.0% YoY), and the annual figure for FY2019 was $11.0, down 89.11%.
  • Interest & Investment Income for Q1 2019 was $10.0 at Nu-Med Plus, down from $35.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $35.0 in Q1 2018 to a low of $1.0 in Q2 2015.
  • The 4-year median for Interest & Investment Income is $4.0 (2015), against an average of $8.29.
  • The sharpest move saw Interest & Investment Income surged 300.0% in 2016, then plummeted 71.43% in 2019.
  • Year by year, Interest & Investment Income stood at $2.0 in 2015, then changed by 0.0% to $2.0 in 2016, then soared by 1650.0% to $35.0 in 2018, then plummeted by 71.43% to $10.0 in 2019.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $10.0, $35.0, and $2.0 for Q1 2019, Q1 2018, and Q3 2016 respectively.